‘Monster’ Florida opioid doctor sentenced after several years, trials
This is part three of three. This report about a Florida doctor, Monster on the Beach, deals with sensitive issues […]
Uncategorized
Uncategorized
Jaypirca (pirtobrutinib) Now Approved by U.S. FDA for the Treatment of Adult Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Who Have Received at Least Two Lines of Therapy, Including a BTK Inhibitor and a BCL-2 Inhibitor
The first and only non-covalent (reversible) BTK inhibitor, Jaypirca has been shown to extend the benefit of BTK inhibition In the
Children increasingly sent to ERs by police in ’emergency evaluations’ for misbehaving at school
The state law that allows for these removals, known as petitions for emergency evaluation, is meant to be limited to